Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC

NCT03246659

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: Department of Nuclear Medicine, Innsbruck Medical University Innsbruck, Austria

Department of Nuclear Medicine, University Hospital Freiburg Freiburg im Breisgau, Germany

Erasmus University Rotterdam Rotterdam, Netherlands

Department of Endocrinology, Jagiellonian University Medical College Krakow, Poland

View Trial Details

Completed

Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma

NCT01363206

Conditions: Malignant Melanoma, Metastatic, Melanoma, Neoplasm Metastasis, +14 more
Locations: Northern Californai Melanoma Center, St. Mary's Medical Center San Francisco, California, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Avelumab in G3 NEC

NCT03278405

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Completed

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

NCT01307267

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations: City of Hope Duarte, California, United States

UC San Diego Moores Cancer Center-Investigational Drug Services La Jolla, California, United States

UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital) La Jolla, California, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

View all 42 locations

View Trial Details

Completed

Effect of Implant Position on Magnetic Resonance Image Distortion

NCT02246231

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: Central Manchester University Hospitals NHS Foundation Trust Manchester, Manchester (Manchester Borough), United Kingdom

View Trial Details

Completed

Study of Karenitecin (BNP1350) to Treat Malignant Melanoma

NCT00062491

Conditions: Melanoma, Neoplasm, Neoplasms, +10 more
Locations: For Information call 210-614-1701 for a site near you Tampa, Florida, United States

View Trial Details

Completed

Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

NCT01449279

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma

NCT00912418

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

NCT00625846

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +29 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Colorado Hospital Aurora, Colorado, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

View all 22 locations

View Trial Details

Completed

Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye

NCT01413191

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Eye Diseases, +17 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions